Skip to content

Derivatives at other companies

Cheniere Energy logo
Cheniere EnergyLNG
$2.23B+118%
Duke Energy logo
Duke EnergyDUK
$336M+106%
LBR
LB Pharmaceuticals Inc Common StockLBRX
$200K-74.0%
Koppers Holdings logo
Koppers HoldingsKOP
$26.2M+330%
Cheniere Energy logo
Cheniere EnergyLNG
$25M-81.5%
Duke Energy logo
Duke EnergyDUK
$160M+300%

Other financials

Income statement

See full
Revenue$841.8M-2.4%
Gross profit$97.6M+8.7%
Operating income$23.8M+1,087%
Net income$10.7M+250%
EPS (diluted)$0.26+230%

Balance sheet

See full
Cash & equivalents$7.3M+8.9%
Total debt$907.3M-1.6%
Total assets$1.0B-7.7%

Cash flow

See full
Operating cash flow$27.9M+85.3%
CapEx$3.4M-66.1%
Free cash flow$24.5M+396%

Valuation

See full
Market cap$831M+5.8%
Enterprise value$1.73B+1.9%
P/E13.9×-9.9×
P/S0.2×0.0×

Profitability

See full
Gross margin11.3%+1.2pp
Operating margin3.3%+1.1pp
Net margin1.6%+0.8pp
FCF margin2.1%+0.4pp

Returns & leverage

See full
Current ratio0.7×-0.2×

Where this comes from

Reported directly by CrossAmerica Partners in its filing.

Tagged under the XBRL concept us-gaap:DerivativeAssetsNoncurrent.

The official record: CrossAmerica Partners’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about CrossAmerica Partners's derivatives.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CrossAmerica Partners's derivatives?
CrossAmerica Partners (CAPL) reported derivatives of $1.08M in Q1 2026.
How has CrossAmerica Partners's derivatives changed year-over-year?
CrossAmerica Partners's derivatives decreased by 41.8% year-over-year, from $1.86M to $1.08M.
What is the long-term trend for CrossAmerica Partners's derivatives?
Over 4 years (2021 to 2025), CrossAmerica Partners's derivatives has grown at a -42.2% compound annual growth rate (CAGR), from $2.92M to $325K.